We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
(-18%)
Cap. Flow
-$5.48B
Cap. Flow
% of AUM
-12.38%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$160M |
| 2 |
S&P Global
SPGI
|
+$159M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$123M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$111M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.01B |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$257M |
| 3 |
Chevron
CVX
|
+$236M |
| 4 |
ExxonMobil
XOM
|
+$224M |
| 5 |
AbbVie
ABBV
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.65% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Industrials | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
HUTCHMED
HCM
$2.34B
| $8.38M | 0.02% |
443,157
-16,400
| -4% | -$418K |
|
652
NeoGenomics
NEO
$2.43B
| $8.38M | 0.02% |
689,667
-1,056,455
| -61% | -$22.2M |
|
653
Tractor Supply
TSCO
$17.1B
| $8.34M | 0.02% |
178,710
+140,375
| +366% | +$6.21M |
|
654
Annexon
ANNX
$745M
| $8.33M | 0.02% |
3,052,651
+1,027,051
| +51% | +$6.32M |
|
655
Koppers
KOP
$884M
| $8.29M | 0.02% |
301,307
-55,734
| -16% | -$1.65M |
|
656
Arch Capital
ACGL
$33.1B
| $8.26M | 0.02% |
170,618
+1,201
| +0.7% | +$55.8K |
|
|
CASI
657
DELISTED
CASI Pharmaceuticals
CASI
| $8.22M | 0.02% |
1,015,000
| – | – |
|
658
Landstar System
LSTR
$5.74B
| $8.14M | 0.02% |
53,988
-569
| -1% | -$90.5K |
|
|
CCRN
659
DELISTED
Cross Country Healthcare
CCRN
| $8.1M | 0.02% |
373,898
-56,636
| -13% | -$1.23M |
|
660
MiMedx Group
MDXG
$690M
| $8.1M | 0.02% |
1,718,749
+1,662,278
| +2,944% | +$8.13M |
|
661
Jack in the Box
JACK
$253M
| $7.99M | 0.02% |
85,500
+17,097
| +25% | +$1.51M |
|
662
Vishay Intertechnology
VSH
$4.8B
| $7.99M | 0.02% |
407,433
+9,371
| +2% | +$189K |
|
663
Minerva Neurosciences
NERV
$166M
| $7.98M | 0.02% |
1,201,275
| – | – |
|
664
PMV Pharmaceuticals
PMVP
$76.4M
| $7.95M | 0.02% |
381,976
+69,955
| +22% | +$1.23M |
|
665
Goldman Sachs
GS
$273B
| $7.88M | 0.02% |
23,864
-216,406
| -90% | -$76.4M |
|
666
Organogenesis Holdings
ORGO
$179M
| $7.85M | 0.02% |
1,030,743
+943,875
| +1,087% | +$7.31M |
|
667
Installed Building Products
IBP
$5.3B
| $7.82M | 0.02% |
92,560
-10,463
| -10% | -$1.11M |
|
668
Cintas
CTAS
$79.8B
| $7.81M | 0.02% |
73,436
-12,060
| -14% | -$1.17M |
|
669
Pinnacle West Capital
PNW
$11.5B
| $7.75M | 0.02% |
99,295
-17,021
| -15% | -$1.22M |
|
670
Purple Innovation
PRPL
$11M
| $7.73M | 0.02% |
+52,835
| New | +$10.4M |
|
671
Align Technology
ALGN
$10.7B
| $7.72M | 0.02% |
17,714
-4,487
| -20% | -$2.18M |
|
672
Adaptive Biotechnologies
ADPT
$4.42B
| $7.72M | 0.02% |
+556,199
| New | +$8.74M |
|
673
Shutterstock
SSTK
$183M
| $7.65M | 0.02% |
82,162
-85,115
| -51% | -$7.9M |
|
674
CACI
CACI
$13.9B
| $7.63M | 0.02% |
25,337
-8,678
| -26% | -$2.4M |
|
675
Inogen
INGN
$136M
| $7.6M | 0.02% |
234,502
+221,991
| +1,774% | +$6.98M |
|
Similar funds
Federated Hermes's Q1 2022 Portfolio in Review
As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.
- Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
- Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
- Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
- Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
- Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
- Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
- Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.
Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.